Sign In  |  Register  

DOI: 10.1007/s11095-010-0130-xPages: 1469-1486

Phospholipids and Lipid-Based Formulations in Oral Drug Delivery

1. Phospholipid Research Center

2. Phospholipid GmbH

3. Ruprecht-Karls-University, Institute of Pharmacy and Molecular Biotechnology

4. Martin-Luther-University, Institute of Chemistry

5. Lipoid GmbH Frigenstr. 4

6. iMEDD Inc.

7. Technical University, Institute of Pharmaceutical Technology

8. Institute of Pharmacy and Molecular Biotechnology

Correspondence to:
Gert Fricker
Tel: +49-6221-548336
Fax: +49-6221-545971
Email: gert.fricker@uni-hd.de

Close

Abstract

Phospholipids become increasingly important as formulation excipients and as active ingredients per se. The present article summarizes particular features of commonly used phospholipids and their application spectrum within oral drug formulation and elucidates current strategies to improve bioavailability and disposition of orally administered drugs. Advantages of phospholipids formulations not only comprise enhanced bioavailability of drugs with low aqueous solubility or low membrane penetration potential, but also improvement or alteration of uptake and release of drugs, protection of sensitive active agents from degradation in the gastrointestinal tract, reduction of gastrointestinal side effects of non-steroidal anti-inflammatory drugs and even masking of bitter taste of orally applied drugs. Technological strategies to achieve these effects are highly diverse and offer various possibilities of liquid, semi-liquid and solid lipid-based formulations for drug delivery optimization.

To access the full text, please Sign in

If you have institutional access, please click here

2680 Views

  • Accepted: Mar 22, 2010
  • Online: Apr 22, 2010

Article Tools